Surmodics Inc reports results for the quarter ended in December - Earnings Summary

SurModics

06/02/2023 22:01

* Surmodics Inc  SRDX.OQ  reported a quarterly adjusted loss
of 50
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 66 cents per share.
    * Revenue rose 8.4% to $24.93 million from a year ago;
analysts
expected $23.97 million. 
    * Surmodics Inc's reported EPS for the quarter was a loss
of 56
cents​.
    * The mean earnings estimate of analysts had fallen by
about 705.6% in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Surmodics Inc shares had fallen by 12.2% this quarter.
    * The company reported a quarterly loss of $7.84 million.
    * Wall Street's median 12-month price target for Surmodics
Inc is
$53.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
6 at 10:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.66          -0.50          Beat
 Sep. 30 2022      -0.45          -0.26          Beat
 Jun. 30 2022      -0.38          -0.34          Beat
 Mar. 31 2022      -0.34          -0.22          Beat